Analysis of the open database and experiments with immunochemistry showed that LRRC4 is lowly expressed in high-grade serous ovarian cancer (HGSC) cells and during EOC metastasis. The gene discussed is LRRC4; the disease is ovarian serous adenocarcinoma.